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ABSTRACT
Massive splenomegaly due to multifocal littoral cell angi-
oma was discovered incidentally in a 55-year-old man
during a workup for an unrelated condition. The tumor
was removed successfully by laparoscopic splenectomy.
We report the second case of littoral cell angioma of the
spleen treated laparoscopically.
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INTRODUCTION
Littoral cell angioma (LCA) of the spleen is a new subtype
of benign vascular tumor that involves the cells that line
the splenic sinus channels. This tumor expresses both
vascular and histiocytic antigens. Splenectomy is both
diagnostic and therapeutic. We present a case of LCA of
the spleen treated successfully with laparoscopic splenec-
tomy. Our review of the literature revealed only 1 other
report of splenic LCA treated laparoscopically.1
CASE HISTORY
A 55-year-old man with a history of right-sided flank pain
presented to the emergency department. The pain was
caused by a right renal stone that passed without treat-
ment. Incidentally on the computed tomographic (CT)
scan that was part of his workup, an abnormally large
spleen with numerous poorly defined hypodense areas
was noted (Figure 1). His past medical history was sig-
nificant for hypertension, type 2 diabetes mellitus, Crohn’s
disease, and obesity, but negative for any family history of
cancer. His previous surgical history included laparo-
scopic cholecystectomy. The patient had no known drug
allergies, and his current medications included calan SR,
enalapril, doxazosin, glyburide, metformin, and asacol.
He had a distant history of tobacco use and used alcohol
occasionally. He denied any constitutional symptoms,
such as fever, night sweats, and chills.
On physical examination, he was a well appearing, obese
man who was 71 inches tall and weighed 315 lbs. His
blood pressure was 176/70 and his heart rate was 92.
Abdominal examination revealed an obese abdomen
without tenderness, distension, masses, hernias, or orga-
nomegaly. The rest of his physical examination was un-
remarkable.
Laboratory results revealed normal white blood cell count
and platelet count. He was slightly anemic with a hemo-
globin of 13.7 g/mL (normal range, 14.0 to 18.0). The
differential count was also within normal limits. The basic
metabolic panel was within normal limits except for glu-
cose of 225 mg/dL (normal range, 70 to 130).
Magnetic resonance imaging confirmed multiple abnor-
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CASE REPORTmal areas of very low signal intensity on T1-weighted
images, and mixed signal intensity was present on the
T2-weighted images. Postcontrast films showed abnormal
enhancement in all of the abnormal areas except 1 medial
area, which resembled a simple cyst.
The differential diagnosis at this point was lymphoma,
metastatic disease, or an infectious process with microab-
scess formation.
During laparoscopic splenectomy, the spleen was noted
to be very large with multiple irregularities on its surface.
It was removed through one 5-mm viewing port and two
5-mm and one 12-mm working ports. The 12-mm port
was enlarged to a 4-cm incision to remove the spleen.
On gross pathology, the spleen weighed 788 grams and
measured 19x10x6 cm. The patient had several spongy
hemorrhagic circumscribed nodules that measured up to 6
cm in diameter. On microscopic pathology, the sectioned
specimen revealed splenic parenchyma with nodular col-
lections of varying sized vascular channels forming dis-
crete but not circumscribed angiomas, some of the spaces
of which showed organizing thromboses separated by
compressed red pulp. The cells lining these varied from
flat to polygonal to cuboidal and had benign uniform
nuclei, sometimes containing hemosiderin pigment,
sometimes were vacuolated, and rarely showed eryth-
rophagocytosis. Histiocytic markers factor 8 immunoper-
oxidase stain and CD68 stained brightly to light up these
cells. No evidence was present of a malignant component.
The patient did well postoperatively and was discharged
to home on postoperative day 2 tolerating a regular diet.
One year postoperatively, he is doing well.
DISCUSSION
Vascular tumors, the most common primary tumors of the
spleen, have been divided into 3 types as differentiated by
level of aggressiveness: benign (hemangiomas, lym-
phangiomas, and hamartomas), intermediate (heman-
gioendotheliomas), and malignant tumors (angiosarco-
mas).2
LCA of the spleen was first described in 1991 as a new
subtype of vascular tumor that arises from the normal
littoral cells that line the sinus channels of the splenic red
pulp and expresses both vascular and histiocytic anti-
gens.3 A malignant subtype, littoral cell angiosarcoma has
also been described and possesses cytologically atypical
cells and malignant morphologic features, such as inva-
sion of surrounding organs.4
Clinically, patients with LCA present with splenomegaly,
thrombocytopenia, anemia, or with constitutional symp-
toms, such a fever of unknown origin. Patients can also
present completely asymptomatically. The male-to-female
distribution is nearly equal.
CT findings consistent with LCA are multiple small ovoid
areas of hypoattenuation on contrast-enhanced CT per-
formed during the portal venous phase. These findings
can also be seen in other primary splenic neoplasms that
lead to diffuse involvement of the spleen. Consequently,
metastatic disease, lymphoma, sarcoidosis, Kaposi’s sar-
coma, or infectious processes that lead to microabscess
formation may mimic LCA.2
LCA has characteristic morphologic and immunohisto-
chemical characteristics that differentiate it from other
vascular splenic tumors. Gross pathology often reveals a
large spleen with multiple nodular lesions. Microscopi-
cally, the lesions vary from narrow sinus-like channels to
large spaces lined with cuboidal to tall pseudopapillated
cells, sometimes containing hemosiderin and red cells.
These spaces are surrounded by compressed red pulp, all
different findings from the more common cavernous hem-
angioma. Immunohistochemical staining for factor 8 and
CD68 are characteristic of LCA, showing both vascular and
histiocytic phenotypes.5 Our patient’s specimen revealed
gross, microscopic, and immunohistochemical changes
diagnostic of splenic LCA.
The treatment for LCA is splenectomy, which is both
diagnostic and therapeutic. Interestingly, one third of the
previously reported cases were associated with either ma-
lignant lymphomas or visceral organ cancer,6 a correlation
that was not seen in our patient.
Figure 1. Computed tomographic scan demonstrating abnor-
mally large spleen (arrow) with multiple hypodense areas.
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clinical entity, scattered reports7 have been made of tu-
mors with more malignant behavior presenting with met-
astatic disease. These patients were found to have micro-
scopic changes consistent with LCA with malignant areas
and areas with cellular atypia. These cases suggest that
due to the subtle differences between benign and malig-
nant tumors, patients should be followed for signs of
recurrence and metastasis.
Our search of the literature revealed only 1 other report in
English of laparoscopic splenectomy for LCA.1 Studies8
have shown laparoscopic splenectomy to be superior to
open splenectomy for certain diseases, such as idiopathic
thrombocytopenic purpura, with its attendant benefits of
decreased pain medication needed, earlier oral intake,
and decreased length of stay. Kercher et al9 found that a
laparoscopic approach was beneficial for massive spleno-
megaly (defined as craniocaudal dimension 17 cm and
weight 600 grams), which is also supported by our
experience with this patient. Brodsky et al10 also support
laparoscopic splenectomy for an assortment of diseases,
even in the setting of splenomegaly. Rosen et al1 found
laparoscopic splenectomy to be safe for both benign and
malignant hematologic conditions, including Idiopathic
Thrombocytopenic Purpura and a case of LCA, with a
conversion rate in their series of 5%. The ability of our
patient to tolerate a regular diet and be discharged by
postoperative day 2, as well as the avoidance of a large
painful subcostal incision that would have hindered pul-
monary toilet in this obese patient, underscore the benefit
of laparoscopic splenectomy.
CONCLUSIONS
Primary tumors of the spleen are quite rare when lym-
phoid and hematologic tumors are excluded. LCA should
be considered in the differential diagnosis of multinodular
splenectomy, especially in the presence of anemia, throm-
bocytopenia, or splenic lesions in the absence of associ-
ated adenopathy. LCA with splenomegaly is amenable to
laparoscopic splenectomy diagnostically and therapeuti-
cally.
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